AION-301

· AION Healthspan, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AION-301, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) [Phase 1, Phase 2]

See pricing